These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 6949545

  • 1. Amrinone--a new inotropic agent in chronic resistant congestive cardiac failure.
    Robinson PJ, Lvoff R, Chong B, Barrett PA.
    Aust N Z J Med; 1981 Dec; 11(6):666-8. PubMed ID: 6949545
    [Abstract] [Full Text] [Related]

  • 2. [Effects of amrinone administered orally and by injection in heart failure].
    Bounhoure JP, Massabuau P, Puel J, Miquel JP, Calazel J.
    Ann Med Interne (Paris); 1985 Dec; 136(3):251-5. PubMed ID: 3896092
    [Abstract] [Full Text] [Related]

  • 3. Non-glycoside, non-catecholamine inotropic agents in the treatment of congestive heart failure.
    Tommaso CL.
    Am J Med; 1986 Feb 28; 80(2B):36-9. PubMed ID: 3004210
    [No Abstract] [Full Text] [Related]

  • 4. Intravenous use of amrinone for the treatment of the failing heart.
    Mancini D, LeJemtel T, Sonnenblick E.
    Am J Cardiol; 1985 Jul 22; 56(3):8B-15B. PubMed ID: 2411122
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical effects of intravenous amrinone in patients with congestive heart failure.
    Goldstein RA.
    Circulation; 1986 Mar 22; 73(3 Pt 2):III191-5. PubMed ID: 3510775
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Intravenous amrinone for congestive heart failure.
    Med Lett Drugs Ther; 1984 Nov 23; 26(675):104-5. PubMed ID: 6390109
    [No Abstract] [Full Text] [Related]

  • 10. Amrinone-mediated thrombocytopenia.
    Kinney EL, Ballard JO, Carlin B, Zelis R.
    Scand J Haematol; 1983 Oct 23; 31(4):376-80. PubMed ID: 6622977
    [Abstract] [Full Text] [Related]

  • 11. Amrinone: a promising new cardiotonic agent in the treatment of chronic cardiac failure.
    Likoff MJ, Weber KT, Andrews V, Janicki JS.
    Herz; 1983 Aug 23; 8(4):199-205. PubMed ID: 6413341
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Relative contribution of inotropic and vasodilator effects to amrinone-induced hemodynamic improvement in congestive heart failure.
    Konstam MA, Cohen SR, Weiland DS, Martin TT, Das D, Isner JM, Salem DN.
    Am J Cardiol; 1986 Feb 01; 57(4):242-8. PubMed ID: 3004184
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Right ventricular hemodynamics and lung function following amrinone injection].
    Klepzig M, Baur X, Hauser F, Mernitz G, Fruhmann G, Strauer BE.
    Z Kardiol; 1984 Oct 01; 73(10):623-7. PubMed ID: 6516514
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of amrinone on myocardial energetics in severe congestive heart failure.
    Baim DS.
    Am J Cardiol; 1985 Jul 22; 56(3):16B-18B. PubMed ID: 3161318
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.